EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Hyperinsulinism-hyperammonemia syndrome due to an autosomal dominant GLUD1 p.Ile497Met mutation

Ayli S Anvaripour iD, Varuna Dhanabal, Ethan Jeffrey Blake, Alden F Dewey iD, Francesco Vetrini, Jamie Lynn Felton iD

JCEM Case Reports · 27.07.2026 · 4 (9)

DOI: 10.1210/jcemcr/luag227 ↗

Kurz gefasst

Fallbericht in der Zeitschrift JCEM Case Reports, online erschienen am 20.08.2026. Verfasst von Ayli S Anvaripour und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN 46202, USA. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hyperinsulinism-hyperammonemia (HI/HA) syndrome is a rare metabolic disorder caused by mutations in GLUD1, which encodes the mitochondrial enzyme glutamate dehydrogenase (GDH). This condition is characterized by recurrent hypoglycemia, elevated plasma ammonia, and potential neurological complications. We report the case of a 12-month-old male who presented with episodic hypoglycemia, hyperammonemia, and seizures. Family history was notable for childhood-onset hypoglycemia and seizures in the patient's mother and sister. The patient's laboratory findings during hospitalization were significant for markedly elevated C-peptide level of 4.9 ng/mL (SI: 1.63 nmol/L) (reference range; 1.1-4.4 ng/mL [SI: 0.36-1.46 nmol/L]). Insulin was inappropriately detectable at 20.2 µIU/mL (SI: 124.92 pmol/L) during hypoglycemia (reference range; 4.00-30.00 µIU/mL [SI: 24.0-180.0 pmol/L]). Genetic testing identified c.1491A>G (p.Ile497Met) in GLUD1. Following initiation of diazoxide therapy, he experienced symptomatic improvement with a marked reduction in hypoglycemic episodes. This case expands the literature on autosomal dominant HI/HA syndrome associated with an inherited GLUD1 p.Ile497Met mutation.

Schlagwörter

Stichwörter der Autor:innen

hyperammonemiahyperinsulinism-hyperammonemia (HI/HA) syndromehypoglycemia

Autor:innen und Institutionen

  • Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
  • Department of Pediatrics, Division of Pediatric Endocrinology, Riley Hospital for Children at Indiana University Health, Indianapolis, IN 46202, USA.
  • Division of Clinical Genetics and Molecular Biology, Indiana University, Indianapolis, IN 46202, USA.

ORCID-Profile: Ayli S Anvaripour, Alden F Dewey, Jamie Lynn Felton

Zitieren

APA

Anvaripour, A. S., Dhanabal, V., Blake, E. J., Dewey, A. F., Vetrini, F., & Felton, J. L. (2026). Hyperinsulinism-hyperammonemia syndrome due to an autosomal dominant GLUD1 p.Ile497Met mutation. JCEM Case Reports, 4(9). https://doi.org/10.1210/jcemcr/luag227

Vancouver

Anvaripour AS, Dhanabal V, Blake EJ, Dewey AF, Vetrini F, Felton JL. Hyperinsulinism-hyperammonemia syndrome due to an autosomal dominant GLUD1 p.Ile497Met mutation. JCEM Case Reports. 2026;4(9). doi:10.1210/jcemcr/luag227

BibTeX
@article{Anvaripour2026,
  author = {Anvaripour, Ayli S and Dhanabal, Varuna and Blake, Ethan Jeffrey and Dewey, Alden F and Vetrini, Francesco and Felton, Jamie Lynn},
  title = {Hyperinsulinism-hyperammonemia syndrome due to an autosomal dominant GLUD1 p.Ile497Met mutation},
  journal = {JCEM Case Reports},
  year = {2026},
  volume = {4},
  number = {9},
  doi = {10.1210/jcemcr/luag227}
}
Kostenlos starten →